Session Detail


Session Title: The Epigenome/Genome in Colorectal Cancer: From Discovery to Therapeutics
Session Type: Current Concepts and Controversies in Organ Site Research
Session Start/End Time: Tuesday, Apr 03, 2012, 10:30 AM -12:30 PM
Location: McCormick Place West (Level 1), Room W190
CME: CME-Designated
CME/CE Hours: 2
Session Description: As a plethora of data are generated from The Cancer Genome Atlas Project in colorectal cancer, it is becoming clear that there are distinct molecular pathways that drive the progression of this disease and may be exploited for novel therapeutics. Likewise, genomic approaches are being used to identify molecular subtypes of CRC that may be responsive to targeted therapies and the genome-wide assessment of resistance mechanisms is leading to rational combination strategies. In this session, the speakers will focus on both the discovery and application of epigenomics and genomics in CRC.
Presentations:
Chairperson
S. Gail Eckhardt. Univ. of Colorado Cancer Ctr., Aurora, CO
Chairperson
Sanford D. Markowitz. Case Western Reserve Univ., Cleveland, OH
Individualized and rational approaches to the treatment of CRC
Tuesday, Apr 03, 2012, 10:30 AM -10:50 AM
S. Gail Eckhardt. Univ. of Colorado Cancer Ctr., Aurora, CO
Discussion
Tuesday, Apr 03, 2012, 10:50 AM -10:55 AM
Genomics-based therapeutic approaches for colorectal cancer
Tuesday, Apr 03, 2012, 10:55 AM -11:15 AM
Raju Kucherlapati. Harvard Medical School, Boston, MA
Discussion
Tuesday, Apr 03, 2012, 11:15 AM -11:20 AM
Exploring the colorectal cancer methylome
Tuesday, Apr 03, 2012, 11:20 AM -11:40 AM
Peter W. Laird. USC, Los Angeles, CA
Discussion
Tuesday, Apr 03, 2012, 11:40 AM -11:45 AM
Genetic opportunities for cancer detection and prevention
Tuesday, Apr 03, 2012, 11:45 AM -12:05 PM
Sanford D. Markowitz. Case Western Reserve Univ., Cleveland, OH
Discussion
Tuesday, Apr 03, 2012, 12:05 PM -12:10 PM
Panel Discussion
Tuesday, Apr 03, 2012, 12:10 PM -12:30 PM